Horizon Pharma plc·4

May 7, 5:03 PM ET

Pauli Ronald 4

4 · Horizon Pharma plc · Filed May 7, 2018

Insider Transaction Report

Form 4
Period: 2018-05-03
Pauli Ronald
Director
Transactions
  • Award

    Restricted Stock Units

    2018-05-03+15,32015,320 total
    From: 2019-05-03Ordinary shares (15,320 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2018-05-03+14,05428,084 total(indirect: By Trust)
  • Tax Payment

    Ordinary Shares

    2018-05-03$13.87/sh3,790$52,56724,294 total(indirect: By Trust)
  • Exercise/Conversion

    Restricted Stock Units

    2018-05-0314,0540 total
    Ordinary shares (14,054 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-05-03+32,16132,161 total
    Exercise: $13.87Exp: 2028-05-02Ordinary shares (32,161 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]On May 3, 2017, the reporting person was granted 14,054 restricted stock units, vesting in full on the first anniversary of the grant date.
  • [F3]The option vests in 12 equal monthly installments from the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION